Literature DB >> 15357954

Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck.

Joseph M Dal Porto1, Kathy Burke, John C Cambier.   

Abstract

Although found predominantly in the peritoneal and pleural cavities, B-1 cells are also present in other peripheral tissues such as spleen and lung. While similar in surface phenotypes, such as CD5, all B-1 cells are not equivalent in their response to stimuli. Here, we report that the src family kinase Lck is required to confer the BCR hyporesponsiveness typical of CD5+ B-1 cells and appears involved in the maintenance of their unique function. Splenic B-1 cells express CD5 but not Lck and are not hyporesponsive; however, within the peritoneum, these B-1 cells are induced to express Lck and acquire a hyporesponsive phenotype. Peritoneal B-1 cells from lck-deficient mice, while CD5+, no longer exhibit attenuated BCR signaling. Interestingly, lck-null mice exhibited increased natural antibody levels characteristic of B-1 cells. Taken together, these results demonstrate a key role for Lck in modulating the signaling and cellular fate of B-1 B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357954     DOI: 10.1016/j.immuni.2004.07.018

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  29 in total

Review 1.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 2.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

3.  Mzb1 protein regulates calcium homeostasis, antibody secretion, and integrin activation in innate-like B cells.

Authors:  Henrik Flach; Marc Rosenbaum; Marlena Duchniewicz; Sola Kim; Shenyuan L Zhang; Michael D Cahalan; Gerhard Mittler; Rudolf Grosschedl
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

4.  Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Authors:  Ganna A Liubchenko; Holly C Appleberry; V Michael Holers; Nirmal K Banda; Van C Willis; Taras Lyubchenko
Journal:  J Autoimmun       Date:  2012-02-24       Impact factor: 7.094

5.  B Cell Subsets Differentially Contribute to the T Cell-Independent Memory Pool.

Authors:  Christina A Daly; M Ariel Spurrier; Jamie E Jennings-Gee; Karen M Haas
Journal:  J Immunol       Date:  2020-09-25       Impact factor: 5.422

6.  2019 Russell Ross Memorial Lecture in Vascular Biology: B Lymphocyte-Mediated Protective Immunity in Atherosclerosis.

Authors:  Aditi Upadhye; Jeffrey M Sturek; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-19       Impact factor: 8.311

7.  Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.

Authors:  Gaofeng Fan; Matthew J Simmons; Sheng Ge; Jui Dutta-Simmons; Jérôme Kucharczak; Yacov Ron; David Weissmann; Chiann-Chyi Chen; Chandreyee Mukherjee; Eileen White; Céline Gélinas
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

8.  CD6 Receptor Regulates Intestinal Ischemia/Reperfusion-induced Injury by Modulating Natural IgM-producing B1a Cell Self-renewal.

Authors:  Gospel Enyindah-Asonye; Yan Li; Wei Xin; Nora G Singer; Neetu Gupta; John Fung; Feng Lin
Journal:  J Biol Chem       Date:  2016-12-01       Impact factor: 5.157

9.  Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.

Authors:  Kazuhito Honjo; Yoshiki Kubagawa; Yusuke Suzuki; Miyuki Takagi; Hiroshi Ohno; R Pat Bucy; Shozo Izui; Hiromi Kubagawa
Journal:  Int Immunol       Date:  2014-07-03       Impact factor: 4.823

10.  CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.

Authors:  Karen M Haas; Kristen L Johnson; James P Phipps; Cardinal Do
Journal:  J Immunol       Date:  2018-01-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.